Orforglipron: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Orforglipron. Educational only — not medical advice.

Labeled uses

FOUNDAYOTM is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.

Source: FDA labeling via NIH DailyMed (set 8ac446c5…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.